Meloxicam Executes Its Antitumor Effects against Hepatocellular Carcinoma in COX-2- Dependent and -Independent Pathways

BACKGROUND: Cyclooxygenase (COX)-2 is overexpressed in many types of cancers including hepatocellular carcinoma (HCC). Meloxicam, a selective COX-2 inhibitor, has shown potential therapeutic effects against HCC, but the mechanisms accounting for its anti-cancer activities remain unclear. METHODS AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Xiaofeng, Li, Rui, Xiu, Peng, Dong, Xuesong, Xu, Zongzhen, Zhai, Bo, Liu, Feng, Jiang, Hongchi, Sun, Xueying, Li, Jie, Qiao, Haiquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968044/
https://www.ncbi.nlm.nih.gov/pubmed/24675684
http://dx.doi.org/10.1371/journal.pone.0092864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968044/
https://www.ncbi.nlm.nih.gov/pubmed/24675684
http://dx.doi.org/10.1371/journal.pone.0092864

Ejemplares similares